Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use V...

FDA Drug Recall #D-1407-2014 — Class II — April 9, 2014

Recall Summary

Recall Number D-1407-2014
Classification Class II — Moderate risk
Date Initiated April 9, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Caraco Pharmaceutical Laboratories, Ltd.
Location Detroit, MI
Product Type Drugs
Quantity 200 vials

Product Description

Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd, Gujarat, India, NDC 47335-154-40

Reason for Recall

Lack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance.

Distribution Pattern

OH

Lot / Code Information

JKM7188A

Other Recalls from Caraco Pharmaceutical Laboratories, Ltd.

Recall # Classification Product Date
D-1510-2014 Class II Cephalexin Capsules, USP, 250 mg, packaged in a... Jun 26, 2014
D-1511-2014 Class II Cephalexin Capsules, USP, 500 mg, packaged in a... Jun 26, 2014
D-1415-2014 Class II Venlafaxine Hydrochloride Extended-Release Tabl... Jun 12, 2014
D-1296-2014 Class III Cetirizine Hydrochloride Chewable Tablets, 5 mg... Apr 9, 2014
D-1297-2014 Class III Children's Cetirizine Hydrochloride Chewable Ta... Apr 9, 2014

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.